Beta-hydroxybutyrate (BHB), an endogenic NLRP3 inflammasome inhibitor, was shown to reduce depressive and anxiety behaviors in rodent models of depression and stress, potentially though decreasing hippocampal TNF-α concentrations [200, 201]. The gene discussed is TNF; the disease is major depressive disorder.